BLTE

Belite Bio
BLTE

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.87B
EV
$1.73B
Shares Outstanding
35.52M
Beta
-1.52

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$85.00
P/E 2025E
-
P/Revenue 2025E
187.21x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Belite Bio, Inc

gainify
BLTE

Belite Bio, Inc

BLTE

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company’s lead product candidate ...

Sector

Healthcare

Industry

Biotechnology

CEO

Lin, Yu-Hsin

Employees

25

IPO Date

2022-04-29

Headquarters

12750 High Bluff Drive, Suite 475, San Diego, California, 92130, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved